| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
0.0001 |
| mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0001 |
| mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
| mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.006 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.008 |
| mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.008 |
| mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.008 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
| mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.009 |